Journal articles on the topic 'Nicotinic partial agonist'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Nicotinic partial agonist.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Gonzalez-Gutierrez, Juan Pablo, Martin Hodar, Franco Viscarra, Pablo Paillali, Nicolás Guerra-Díaz, Hernán Pessoa-Mahana, Juan José Hernández-Morantes, et al. "Minimal Structural Changes Determine Full and Partial Nicotinic Receptor Agonist Activity for Nicotine Analogues." Molecules 24, no. 15 (July 24, 2019): 2684. http://dx.doi.org/10.3390/molecules24152684.
Full textHussy, N., M. Ballivet, and D. Bertrand. "Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits." Journal of Neurophysiology 72, no. 3 (September 1, 1994): 1317–26. http://dx.doi.org/10.1152/jn.1994.72.3.1317.
Full textJamali, Qutub. "Galantamine as a Treatment Option for Nicotine Addiction." Journal of Smoking Cessation 2021 (July 17, 2021): 1–3. http://dx.doi.org/10.1155/2021/9975811.
Full textJancin, Bruce. "Selective Nicotinic Receptor Partial Agonist May Be Cessation Advance." Family Practice News 35, no. 13 (July 2005): 34. http://dx.doi.org/10.1016/s0300-7073(05)70953-1.
Full textPotasiewicz, Agnieszka, Joanna Golebiowska, Piotr Popik, and Agnieszka Nikiforuk. "Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α7-nicotinic acetylcholine receptors." Journal of Psychopharmacology 33, no. 1 (December 3, 2018): 62–73. http://dx.doi.org/10.1177/0269881118812097.
Full textMcCaul, Mary E., Gary S. Wand, Hiroto Kuwabara, Robert F. Dannals, Dean Wong, and Xiaoqiang Xu. "The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans." Nicotine & Tobacco Research 22, no. 6 (May 16, 2019): 892–99. http://dx.doi.org/10.1093/ntr/ntz080.
Full textAkinola, Lois S., Deniz Bagdas, Yasmin Alkhlaif, Asti Jackson, Cenk O. Gurdap, Elnaz Rahimpour, F. Ivy Carroll, Roger L. Papke, and M. Imad Damaj. "Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice." Journal of Psychopharmacology 36, no. 11 (November 2022): 1280–93. http://dx.doi.org/10.1177/02698811221132214.
Full textKerr, Jessica L., Erin M. Timpe, and Julie P. Karpinski. "Varenicline: A Novel Nicotinic Receptor Partial Agonist for Smoking Cessation." Journal of Pharmacy Technology 23, no. 1 (January 2007): 23–29. http://dx.doi.org/10.1177/875512250702300105.
Full textDunbar, Geoffrey C., and Ramana Kuchibhatla. "Cognitive Enhancement in Man With Ispronicline, A Nicotinic Partial Agonist." Journal of Molecular Neuroscience 30, no. 1-2 (2006): 169–72. http://dx.doi.org/10.1385/jmn:30:1:169.
Full textCoe, Jotham W., Paige R. Brooks, Michael G. Vetelino, Michael C. Wirtz, Eric P. Arnold, Jianhua Huang, Steven B. Sands, et al. "Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation." Journal of Medicinal Chemistry 48, no. 10 (April 23, 2005): 3474–77. http://dx.doi.org/10.1021/jm050069n.
Full textKoelsch, Gerald, Michael J. Detke, Karen E. Stevens, Leonard T. Meltzer, Alvin V. Terry, Patrick M. Callahan, Ryan F. Yoshimura, et al. "APN1125: A clinical stage α7 nicotinic acetylcholine receptor partial agonist." Biochemical Pharmacology 97, no. 4 (October 2015): 636. http://dx.doi.org/10.1016/j.bcp.2015.08.042.
Full textLiu, Yi, and James P. Dilger. "Decamethonium is a partial agonist at the nicotinic acetylcholine receptor." Synapse 13, no. 1 (January 1993): 57–62. http://dx.doi.org/10.1002/syn.890130108.
Full textGrosshans, M., J. Mutschler, D. Hermann, F. Kiefer, and A. Diehl. "Is Varenicline Able to Prevent Smoking Cessation Induced Affective Symptoms?" European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70656-x.
Full textRaines, Douglas E., and Vinu T. Zachariah. "Isoflurane Increases the Apparent Agonist Affinity of the Nicotinic Acetylcholine Receptor by Reducing the Microscopic Agonist Dissociation Constant." Anesthesiology 92, no. 3 (March 1, 2000): 775–85. http://dx.doi.org/10.1097/00000542-200003000-00021.
Full textIanosi, Edith Simona, Paraschiva Postolache, Luana Andreea Macovei, Mioara Szathmary, Simona Szasz, Roxana Maria Nemes, and Gabriela Jimborean. "Smoking Cessation in COPD Patients by a Selective Partial Nicotinic Agonist." Revista de Chimie 69, no. 7 (August 15, 2018): 1766–69. http://dx.doi.org/10.37358/rc.18.7.6413.
Full textHäggblad, J., H. Eriksson, and E. Heilbronn. "Oxotremorine Acts as a Partial Nicotinic Agonist on Cultured Chick Myotubes." Acta Pharmacologica et Toxicologica 57, no. 5 (March 13, 2009): 317–21. http://dx.doi.org/10.1111/j.1600-0773.1985.tb00051.x.
Full textKoelsch, Gerald, Leonard T. Meltzer, Ryan F. Yoshimura, Alvin V. Terry, Patrick M. Callahan, Geoffrey Bilcer, John Ng, Raymond Ng, Kelvin W. Gee, and Terence A. Kelly. "P4-373: APN1125: A NOVEL A7 NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONIST." Alzheimer's & Dementia 10 (July 2014): P925. http://dx.doi.org/10.1016/j.jalz.2014.07.142.
Full textNides, Mitchell. "Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist." Archives of Internal Medicine 166, no. 15 (August 14, 2006): 1561. http://dx.doi.org/10.1001/archinte.166.15.1561.
Full textMihalak, Karla B., F. Ivy Carroll, and Charles W. Luetje. "Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors." Molecular Pharmacology 70, no. 3 (June 9, 2006): 801–5. http://dx.doi.org/10.1124/mol.106.025130.
Full textPapke, Roger L., Hillary C. Schiff, Brian A. Jack, and Nicole A. Horenstein. "Molecular dissection of tropisetron, an α7 nicotinic acetylcholine receptor-selective partial agonist." Neuroscience Letters 378, no. 3 (April 2005): 140–44. http://dx.doi.org/10.1016/j.neulet.2004.12.025.
Full textWilson, Robert D., Ed Cleator, Michael S. Ashwood, Matthew M. Bio, Karel M. J. Brands, Antony J. Davies, Ulf-H. Dolling, et al. "Development of a Scaleable Synthesis of a Partial Nicotinic Acid Receptor Agonist." Organic Process Research & Development 13, no. 3 (May 15, 2009): 543–47. http://dx.doi.org/10.1021/op800290t.
Full textToffey, Brittany A., Marcie Rabin, and Roger Kurlan. "Withdrawal-Emergent Dyskinesias following Varenicline Therapy." Open Neurology Journal 9, no. 1 (June 8, 2015): 7–8. http://dx.doi.org/10.2174/1874205x01509010007.
Full textNirogi, Ramakrishna, Venkatesh Goura, Renny Abraham, and Pradeep Jayarajan. "α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain." European Journal of Pharmacology 712, no. 1-3 (July 2013): 22–29. http://dx.doi.org/10.1016/j.ejphar.2013.04.021.
Full textKozak, Karolina, Sarah S. Dermody, Maryam Sharif-Razi, Alexandria S. Coles, Marya Morozova, Victoria C. Wing, Sherry A. McKee, and Tony P. George. "Effects of the Nicotinic Partial Agonist Varenicline on Smoking Lapse Behaviour in Schizophrenia." Canadian Journal of Addiction 10, no. 2 (June 2019): 27–35. http://dx.doi.org/10.1097/cxa.0000000000000052.
Full textTonstad, Serena. "Smoking Cessation Efficacy and Safety of Varenicline, an α4β2 Nicotinic Receptor Partial Agonist." Journal of Cardiovascular Nursing 21, no. 6 (November 2006): 433–36. http://dx.doi.org/10.1097/00005082-200611000-00004.
Full textCucchiaro, Giovanni, Yingxian Xiao, Alfredo Gonzalez-Sulser, and Kenneth J. Kellar. "Analgesic Effects of Sazetidine-A, a New Nicotinic Cholinergic Drug." Anesthesiology 109, no. 3 (September 1, 2008): 512–19. http://dx.doi.org/10.1097/aln.0b013e3181834490.
Full textDunbar, Geoffrey C., Fraser Inglis, Ramana Kuchibhatla, Tonmoy Sharma, Mark Tomlinson, and James Wamsley. "Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI)." Journal of Psychopharmacology 21, no. 2 (March 2007): 171–78. http://dx.doi.org/10.1177/0269881107066855.
Full textEddins, Donnie, Lisa K. Lyford, Jung Weon Lee, Sanjay A. Desai, and Robert L. Rosenberg. "Permeant but not impermeant divalent cations enhance activation of nondesensitizing α7 nicotinic receptors." American Journal of Physiology-Cell Physiology 282, no. 4 (April 1, 2002): C796—C804. http://dx.doi.org/10.1152/ajpcell.00453.2001.
Full textCartereau, Alison, Emiliane Taillebois, Jean-Yves Le Questel, and Steeve H. Thany. "Mode of Action of Neonicotinoid Insecticides Imidacloprid and Thiacloprid to the Cockroach Pameα7 Nicotinic Acetylcholine Receptor." International Journal of Molecular Sciences 22, no. 18 (September 13, 2021): 9880. http://dx.doi.org/10.3390/ijms22189880.
Full textRowland, Martin, Carrie Foust Koenigsfeld, and Geoffrey C. Wall. "Possible Exacerbation of Crohn's Disease Caused By Varenicline." Journal of Smoking Cessation 3, no. 1 (April 1, 2008): 63–65. http://dx.doi.org/10.1375/jsc.3.1.63.
Full textLevin, Edward D., Amir H. Rezvani, Yingxian Xiao, Susan Slade, Marty Cauley, Corinne Wells, Dawn Hampton, et al. "Sazetidine-A, a Selective α4β2 Nicotinic Receptor Desensitizing Agent and Partial Agonist, Reduces Nicotine Self-Administration in Rats." Journal of Pharmacology and Experimental Therapeutics 332, no. 3 (December 10, 2009): 933–39. http://dx.doi.org/10.1124/jpet.109.162073.
Full textLam, Sum, and Priti N. Patel. "Varenicline: A Selective ??4??2 Nicotinic Acetylcholine Receptor Partial Agonist Approved for Smoking Cessation." Cardiology in Review 15, no. 3 (May 2007): 154–61. http://dx.doi.org/10.1097/01.crd.0000260270.12829.45.
Full textBiton, Bruno, Olivier E. Bergis, Frédéric Galli, Alain Nedelec, Alistair W. Lochead, Samir Jegham, Danielle Godet, et al. "SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile." Neuropsychopharmacology 32, no. 1 (October 4, 2006): 1–16. http://dx.doi.org/10.1038/sj.npp.1301189.
Full textTasso, Bruno, Federica Novelli, Fabio Sparatore, Francesca Fasoli, and Cecilia Gotti. "(+)-Laburnamine, a Natural Selective Ligand and Partial Agonist for the α4β2 Nicotinic Receptor Subtype." Journal of Natural Products 76, no. 4 (March 5, 2013): 727–31. http://dx.doi.org/10.1021/np3007028.
Full textBrown, Laurence A., Makoto Ihara, Steven D. Buckingham, Kazuhiko Matsuda, and David B. Sattelle. "Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors." Journal of Neurochemistry 99, no. 2 (October 2006): 608–15. http://dx.doi.org/10.1111/j.1471-4159.2006.04084.x.
Full textFaessel, Hélène M., Megan A. Gibbs, David J. Clark, Kevin Rohrbacher, Marilyn Stolar, and Aaron H. Burstein. "Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers." Journal of Clinical Pharmacology 46, no. 12 (December 2006): 1439–48. http://dx.doi.org/10.1177/0091270006292624.
Full textSteensland, P., J. A. Simms, J. Holgate, J. K. Richards, and S. E. Bartlett. "Varenicline, an 4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking." Proceedings of the National Academy of Sciences 104, no. 30 (July 11, 2007): 12518–23. http://dx.doi.org/10.1073/pnas.0705368104.
Full textTheng, Yoong Mei, Suzaily Wahab, Noor Alaudin A. Wahab, Hatta Sidi, and Srijit Das. "Schizophrenia and Nicotine Dependence: What Psychopharmacological Treatment Options are Available for the Duo Perturbationes?" Current Drug Targets 20, no. 2 (December 19, 2018): 173–81. http://dx.doi.org/10.2174/1389450118666171017163741.
Full textRadchenko, E., O. Dravolina, and A. Bespalov. "P.6.011 Pharmacological profile of the nicotinic receptor partial agonist cytisine: effects on maintenance and relapse to nicotine seeking." European Neuropsychopharmacology 21 (April 2011): S165—S166. http://dx.doi.org/10.1016/s0924-977x(11)70212-7.
Full textHu, Yiping, Ruoxi Liu, Jinchao Li, Ye Yue, Wenxiang Cheng, and Peng Zhang. "Attenuation of Collagen-Induced Arthritis in Rat by Nicotinic Alpha7 Receptor Partial Agonist GTS-21." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/325875.
Full textWallace, Tanya L., Patrick M. Callahan, Ashok Tehim, Daniel Bertrand, Geoffrey Tombaugh, Shaojie Wang, Walter Xie, et al. "RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents." Journal of Pharmacology and Experimental Therapeutics 336, no. 1 (October 19, 2010): 242–53. http://dx.doi.org/10.1124/jpet.110.171892.
Full textDéglise, Patrice, Bernd Grünewald, and Monique Gauthier. "The insecticide imidacloprid is a partial agonist of the nicotinic receptor of honeybee Kenyon cells." Neuroscience Letters 321, no. 1-2 (March 2002): 13–16. http://dx.doi.org/10.1016/s0304-3940(01)02400-4.
Full textFarook, Justin M., Ben Lewis, Justin G. Gaddis, John M. Littleton, and Susan Barron. "Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice." Physiology & Behavior 97, no. 3-4 (June 2009): 503–6. http://dx.doi.org/10.1016/j.physbeh.2009.02.031.
Full textCrunelle, Cleo L., Michelle L. Miller, Jan Booij, and Wim van den Brink. "The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review." European Neuropsychopharmacology 20, no. 2 (February 2010): 69–79. http://dx.doi.org/10.1016/j.euroneuro.2009.11.001.
Full textBreining, Scott R., John F. Genus, J. Pike Mitchener, Timothy J. Cuthbertson, Ronald Heemstra, Matt S. Melvin, Gary M. Dull, and Daniel Yohannes. "Development of a Scalable Synthesis of a Pyridinyl-3-azabicyclononene, a Novel Nicotinic Partial Agonist." Organic Process Research & Development 17, no. 3 (February 21, 2013): 413–21. http://dx.doi.org/10.1021/op400002r.
Full textKuang, Shanming, Pingsheng Zhang, Eric Z. Dong, Geremia Jennings, Baoshu Zhao, and Michael Pierce. "Crystal form control and particle size control of RG3487, a nicotinic α7 receptor partial agonist." International Journal of Pharmaceutics 508, no. 1-2 (July 2016): 109–22. http://dx.doi.org/10.1016/j.ijpharm.2016.04.066.
Full textTonstad, Serena, and Charl Els. "Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity." Clinical Medicine Insights: Therapeutics 2 (January 2010): CMT.S4012. http://dx.doi.org/10.4137/cmt.s4012.
Full textSzczupak, L., J. Edgar, ML Peralta, and WB Kristan. "Long-lasting depolarization of leech neurons mediated by receptors with a nicotinic binding site." Journal of Experimental Biology 201, no. 12 (June 15, 1998): 1895–906. http://dx.doi.org/10.1242/jeb.201.12.1895.
Full textBobak, Alex. "Varenicline: Implications for the Field." Journal of Smoking Cessation 2, S1 (December 1, 2007): 8–11. http://dx.doi.org/10.1375/jsc.2.supp.8.
Full textSTRANG, CHRISTIANNE E., JORDAN M. RENNA, FRANKLIN R. AMTHOR, and KENT T. KEYSER. "Nicotinic acetylcholine receptor expression by directionally selective ganglion cells." Visual Neuroscience 24, no. 4 (July 2007): 523–33. http://dx.doi.org/10.1017/s0952523807070435.
Full text